Mark Anthony McCamish Insider Trading $VINCU Vincerx Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Anthony McCamish.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Anthony McCamish. Mark Anthony McCamish is SVP & CMO in PDL BIOPHARMA, INC. ($PDLI) and Director in AVADEL PHARMACEUTICALS PLC ($AVDL) and President and CEO in Forty Seven, Inc. ($FTSV) and Director in Vincera Pharma, Inc. ($LSAC).
Mark Anthony McCamish in Vincerx Pharma, Inc.
Trading Symbol: VINCUIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Anthony McCamish: Director
Holdings: 0 shares
Latest Transaction: Dec 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark Anthony McCamish in Vincerx Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVDL, FTSV, PDLI, VINCU
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 28 2020 | LSAC | Vincera Pharma, In ... | McCamish Mark Anthony | Director | Option Exercise | A | 19.00 | 6,667 | 126,673 | 6,667 |
Page: 1